Evidence map›Paper›PMID 41402330›Full record

ArticleNPJ breast cancer2025

Author Correction: Advancing equitable access to innovation in breast cancer.

Seamus O'Reilly, Ines Vaz Luis, Virginie Adam, Evangelia D Razis, Ander Urruticoechea, Amal Arahmani, Eva Carrasco, Boon H Chua, Judith Bliss, Carolyn Straehle and 9 more

Abstract readPublished Erratum
In one paragraph

Article in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Seamus O'ReillyCancer Trials Ireland, Royal College of Surgeons, Dublin, Ireland.ORCID http://orcid.org/0000-0002-2887-7336
Ines Vaz LuisInstitute Gustave Roussy, Villejuif, France.ORCID http://orcid.org/0000-0002-7194-2260
Virginie AdamBreast International Group, Brussels, Belgium.ORCID http://orcid.org/0000-0002-5271-7287
Evangelia D Razis3rd Oncology Department, Hygeia Hospital, Marousi, Athens, Greece.ORCID http://orcid.org/0000-0003-3873-2947
Ander UrruticoecheaR&D department, Fundación Onkologikoa, Donostia-San Sebastian, Spain.ORCID http://orcid.org/0000-0003-0359-3641
Amal ArahmaniBreast International Group, Brussels, Belgium.
Eva CarrascoGEICAM Spanish Breast Cancer Group, Av de Los Pinneos. 28703 San Sebastian de los Reyes, Madrid, Spain.ORCID http://orcid.org/0000-0002-2771-7197
Boon H ChuaFaculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-7561-7174
Judith BlissThe Institute of Cancer Research, ICR_CTSU, London, UK.ORCID http://orcid.org/0000-0001-7957-7424
Carolyn StraehleBreast International Group, Brussels, Belgium.
Theodora GouliotiBreast International Group, Brussels, Belgium.ORCID http://orcid.org/0009-0006-0178-5120
Barbro LindholmInstitution of Clinical Sciences, Dept of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-1531-630X
Gustavo WerutskyLatin American Cooperative Oncology Group, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0001-6271-105X
Etienne BrainInstitut Curie-Hôpital Rene Huguenin, Saint-Cloud, France.ORCID http://orcid.org/0000-0003-0881-9371
Philippe L BedardDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-6771-2999
Giuseppe CuriglianoEarly Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0003-1781-2518
Sherene LoiSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-6137-9171
Shigehira SajiDepartment of Medical Oncology, Fukushima Medical University, Fukushima, Japan.ORCID http://orcid.org/0000-0002-6732-8030
David CameronUniversity of Edinburgh Cancer Center, Western General Hospital, EDINBURGH United Kingdom, Edinburgh, UK. D.Cameron@ed.ac.uk.ORCID http://orcid.org/0000-0001-6097-2256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41402330
PMCPMC12708722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.